Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT00246012
Status:
COMPLETED
Last Update Posted:
2013-08-19
First Post:
2005-10-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma
Sponsor:
Centocor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-28
First Submit QC Date:
None
Study First Post Date:
2005-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-01
Results First Submit QC Date:
None
Results First Post Date:
2013-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-17
Last Update Post Date:
2013-08-19
Last Update Post Date Type:
ESTIMATED